Aeglea BioTherapeutics is a holding company. Through its subsidiaries, the company is a biotechnology company developing human enzyme therapeutics as disruptive solutions for rare and other high-burden diseases. The company's development programs include: Pegzilarginase in Arginase 1 Deficiency, which is a recombinant human Arginase 1 that enzymatically degrades the amino acid arginine and improves the stability and arginine-degrading activity of the enzyme in human plasma; and ACN00177 in Homocystinuria, which is a PEGylated, or polyethylene glycol modified, human enzyme engineered to degrade free homocysteine and homocystine. The company's preclinical pipeline includes AEB5100 Program in Cystinuria.

Axcella Health is a biotechnology company pioneering the research and development of novel multifactorial interventions to support health and address dysregulated metabolism across a broad spectrum of consumers and patients who have limited options. The company's AXA Candidates are generated from its proprietary, human-focused AXA Development Platform and harness the power of endogenous metabolic modulators, or EMMs, a broad family of molecules that fundamentally impact and regulate human metabolism.

Barnes & Noble Education is a contract operator of physical and virtual bookstores for college and university campuses and K-12 institutions. The company is also a textbook wholesaler, inventory management hardware and software provider, and a provider of digital education solutions. The company's segments are: Retail, which provides a range of course materials, including new and used print and digital textbooks; Wholesale, which provides a selection of new and used textbooks as well as sells hardware and a software suite of applications that provides inventory management and point-of-sale solutions; and DSS, which includes direct-to-student product and service to assist students to study.

ExlService Holdings is a holding company. Through its subsidiaries, the company is an operations management and analytics company. The company's operations management services involve the transfer to the company's business operations of a client such as claims processing, clinical operations, or financial transaction processing, after which the company administers and manages those operations for its client on an ongoing basis, or in case of consulting, consulting services related to transformation services, including digital transformation services. The company's Analytics services focus on driving business outcomes for its customers by generating data-driven insights across various parts of its customers' business.

Kennedy Wilson Holdings is a real estate investment company. The company owns, operates, and invests in real estate both on its own and through its investment management platform. The company focuses primarily on multifamily and office properties located in the Western U.S., U.K., and Ireland. The company also provides real estate services primarily to financial services clients. The company has two primary business units: KW Investments, which invests the company's capital in real estate-related assets; and KW Investment Management and Real Estate Services, which encompasses the company's fee-generating businesses and includes investment management platform and the property services platform.

Myers Industries manufactures a range of polymer products for industrial, agricultural, automotive, commercial and consumer markets. The company has two business segments: Material Handling and Distribution. The Material Handling segment manufactures polymer packaging containers, storage and safety products, and specialty molded parts. The brands within this segment include Buckhorn?, Akro-Mils?, Jamco Products, Ameri-Kart?, and Scepter. The company's Distribution segment includes the Myers Tire Supply?, Myers Tire Supply International? and Patch Rubber Company? brands. Within the Distribution Segment Co. sources and manufactures products for the tire, wheel and undervehicle service industry.

Net 1 UEPS Technologies provides financial technology, products and services. The company has developed and owns most of its payment technologies, and where possible, utilizes this technology to provide financial and services to its customers by including them into the formal financial system. The company's primary payment technology is called the Universal Electronic Payment System (UEPS), and its EMV interoperable derivative, UEPS/EMV, utilizes a form of distributed ledger technology, providing decentralized and biometrically secure smart cards that operate in real-time but both off-line and on-line. The company's financial inclusion products and services are delivered through its UEPS-based core banking system.

Psychemedics is a provider of hair testing for drugs of abuse, utilizing a patented hair analysis method involving digestion of hair, enzyme immunoassay technology and confirmation by mass spectrometry to analyze human hair to detect abused substances. The company's tests provide quantitative information that can indicate the approximate amount of drug ingested as well as historical data. This information is used by employers for both applicant and employee testing, as well as by treatment personnel, law enforcement agencies, school administrators and parents concerned about their children's drug use. In addition, the company provides a test for alcohol using hair.